Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empiric Daptomycin for Neutropenic Fever in Cancer Patients
NCT00335478Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Dec 2006
- Primary completion
- Oct 2008
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daptomycin in neutropenic fever, sponsored by OHSU Knight Cancer Institute. Started Dec 2006; status: completed.
02
Drugs
daptomycin
03
Conditions
neutropenic fever
Beyond the preview
Go deeper on NCT00335478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335478.